Sign in / Join Now
ETFs & Funds
Joseph P. Porter
stops its inotuzumab trials for non-Hodgkin's Lymphoma; trials still planned for Leukemia. Look for bad-news drop.
Add a reply...
Latest StockTalks »
people get PFE breaking news and analysis by email alert.
Get email alerts on PFE »
Get latest price
From other sites
Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal
at TheStreet (Thu, 3:18PM)
Pfizer Inks a $1.6 Billion Deal with AstraZeneca
at Investopedia (Thu, 1:18PM)
Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
at Benzinga (Wed, 2:42PM)
AstraZeneca and Pfizer strike $1.6bn antibiotics deal
at Financial Times (Wed, 2:19PM)
Why Pfizer's Latest Deal Could Send Its Shares Soaring
at TheStreet (Wed, 9:04AM)